Study raises questions over PET (positron emission tomography) for breast cancer
This article was originally published in Clinica
Executive Summary
A US new technology assessment has raised questions about the merits of using positron emission tomography (PET) for breast cancer. The assessment comes only days before a panel of experts is scheduled to meet to discuss whether Medicare should cover such uses.